Mylan Pharmaceuticals Inc has been granted approval for its Abbreviated New Drug Application for Quinapril Tablets USP, 5 mg, 10 mg, 20 mg, and 40 mg by the US FDA. Quinapril Tablets are the generic version of Pfizer Pharmaceuticals' Accupril Tablets.
Mylan Laboratories Inc. is a leading pharmaceutical company with four subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc., UDL Laboratories, Inc. and Mylan Bertek Pharmaceuticals Inc., that develop, license, manufacture, market and distribute an extensive line of generic and proprietary products.